(Q51569923)

7 April 2018

review article

1 reference

title

The role of IGFs in catabolism. (English)

1 reference

7 April 2018

author name string

Botfield C

series ordinal

1

1 reference

7 April 2018

Ross RJ

series ordinal

2

1 reference

7 April 2018

Hinds CJ

series ordinal

3

1 reference

7 April 2018

publication date

1 December 1997

1 reference

7 April 2018

Bailliere's clinical endocrinology and metabolism

published in

1 reference

7 April 2018

volume

11

1 reference

7 April 2018

page(s)

679-697

1 reference

7 April 2018

issue

4

1 reference

7 April 2018

Circulating binding proteins for the insulinlike growth factors.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2897%2980958-5

7 January 2021

Binding proteins for the insulin-like growth factors: structure, regulation and function

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2897%2980958-5

7 January 2021

The role of insulin-like growth factor I in growth of diabetic rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2897%2980958-5

7 January 2021

In vivo proteolysis of serum insulin-like growth factor (IGF) binding protein-3 results in increased availability of IGF to target cells

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2897%2980958-5

7 January 2021

Insulin-like growth factor I binding in hepatocytes from human liver, human hepatoma, and normal, regenerating, and fetal rat liver

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2897%2980958-5

7 January 2021

The Effects of Repeated Daily Recombinant Human Insulin-like Growth Factor I Administration in Adolescents with Type 1 Diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2897%2980958-5

7 January 2021

Reversal of diet-induced catabolism by infusion of recombinant insulin-like growth factor-I in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2897%2980958-5

7 January 2021

The regulation of insulin-like growth factor binding protein (IGFBP)-1 during prolonged fasting.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2897%2980958-5

7 January 2021

The differential regulation of the circulating levels of the insulin-like growth factors and their binding proteins (IGFBP) 1, 2 and 3 after elective abdominal surgery.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2897%2980958-5

7 January 2021

The induction of specific proteases for insulin-like growth factor-binding proteins following major heart surgery

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2897%2980958-5

7 January 2021

Insulin-like growth factors I and II. Peptide, messenger ribonucleic acid and gene structures, serum, and tissue concentrations

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2897%2980958-5

7 January 2021

Impaired actions of insulin-like growth factor 1 on protein Synthesis and degradation in skeletal muscle of rats with chronic renal failure. Evidence for a postreceptor defect

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2897%2980958-5

7 January 2021

Metabolic effects of recombinant human growth hormone: isotopic studies in the postabsorptive state and during total parenteral nutrition

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2897%2980958-5

7 January 2021

Nutritionally-induced changes in hepatic insulin-like growth factor I (IGF-I) gene expression in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2897%2980958-5

7 January 2021

Differential tissue regulation of insulin-like growth factor-I content and binding proteins after endotoxin

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2897%2980958-5

7 January 2021

Hormonal control of muscle growth

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2897%2980958-5

7 January 2021

Therapeutic potential of insulinlike growth factor i.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2897%2980958-5

7 January 2021

NG-monomethyl-L-arginine inhibits the blood flow but not the insulin-like response of forearm muscle to IGF- I: possible role of nitric oxide in muscle protein synthesis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2897%2980958-5

7 January 2021

Growth hormone and insulin-like growth factors in critical illness

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2897%2980958-5

7 January 2021

The endocrine role of insulin-like growth factor I.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2897%2980958-5

7 January 2021

Repeated administration of recombinant human insulin-like growth factor-I in patients after gastric surgery. Effect on metabolic and hormonal patterns

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2897%2980958-5

7 January 2021

A dual effector theory of growth-hormone action

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2897%2980958-5

7 January 2021

Short-term metabolic effects of recombinant human insulin-like growth factor I in healthy adults

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2897%2980958-5

7 January 2021

Relationship of somatomedin-C/insulin-like growth factor I levels to conventional nutritional indices in critically ill patients

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2897%2980958-5

7 January 2021

Identification and characterization of specific binding proteins for growth hormone in normal human sera

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2897%2980958-5

7 January 2021

Effects of recombinant human growth hormone on donor-site healing in severely burned children

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2897%2980958-5

7 January 2021

Insulin-like growth factors; autocrine, paracrine or endocrine? New perspectives of the somatomedin hypothesis in the light of recent developments

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2897%2980958-5

7 January 2021

Human growth hormone prevents the protein catabolic side effects of prednisone in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2897%2980958-5

7 January 2021

Acute effects of insulin-like growth factor I on glucose and amino acid metabolism in the awake fasted rat. Comparison with insulin

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2897%2980958-5

7 January 2021

Low-dose growth hormone and hypocaloric nutrition attenuate the protein-catabolic response after major operation

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2897%2980958-5

7 January 2021

Insulin-like growth factor-binding proteins (IGFBPs) and their regulatory dynamics

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2897%2980958-5

7 January 2021

Hypercalcemia associated with the use of human growth hormone in an adult surgical intensive care unit

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2897%2980958-5

7 January 2021

Passive immunization against circulating insulin-like growth factor-I (IGF-I) increases protein catabolism in lambs: evidence for a physiological role for circulating IGF-I

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2897%2980958-5

7 January 2021

IGF-I potentiates interleukin-2 production in human peripheral T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2897%2980958-5

7 January 2021

Enhancement of the anabolic effects of growth hormone and insulin-like growth factor I by use of both agents simultaneously.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2897%2980958-5

7 January 2021

IGF-I stimulates muscle glucose uptake during sepsis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2897%2980958-5

7 January 2021

Insulin-like growth factor binding protein-3 is functionally altered in pregnancy plasma.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2897%2980958-5

7 January 2021

Effect of postoperative insulin-like growth factor I supplementation on protein metabolism in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2897%2980958-5

7 January 2021

Growth hormone receptor and serum binding protein: purification, cloning and expression

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2897%2980958-5

7 January 2021

Anabolic effects of recombinant insulin-like growth factor-I in cachectic patients with the acquired immunodeficiency syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2897%2980958-5

7 January 2021

Growth hormone stimulates protein synthesis during hypocaloric parenteral nutrition. Role of hormonal-substrate environment

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2897%2980958-5

7 January 2021

Insulin-like growth factors in the fed and fasted states.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2897%2980958-5

7 January 2021

Administration of human recombinant insulin‐like growth factor‐I to patients following major gastrointestinal surgery

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2897%2980958-5

7 January 2021

Insulin-like growth factor-1 (IGF-1) in mice reduces weight loss during starvation

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2897%2980958-5

7 January 2021

The effect of growth hormone on weight gain and pulmonary function in patients with chronic obstructive lung disease

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2897%2980958-5

7 January 2021

Lack of effects of recombinant growth hormone on muscle function in patients requiring prolonged mechanical ventilation: a prospective, randomized, controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2897%2980958-5

7 January 2021

Postoperative positive nitrogen balance with intravenous hyponutrition and growth hormone

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2897%2980958-5

7 January 2021

Reduction in circulating IGF-I and hepatic IGF-I mRNA levels after caecal ligation and puncture are associated with differential regulation of hepatic IGF-binding protein-1, -2 and -3 mRNA levels

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2897%2980958-5

7 January 2021

Growth hormone secretion: its regulation and the influence of nutritional factors

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2897%2980958-5

7 January 2021

Acquired growth hormone resistance

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2897%2980958-5

7 January 2021

Critically ill patients have high basal growth hormone levels with attenuated oscillatory activity associated with low levels of insulin-like growth factor-I.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2897%2980958-5

7 January 2021

Expression of IGF-I and IGF-binding protein genes in cirrhotic liver

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2897%2980958-5

7 January 2021

A comparison of the effects of IGF-I and insulin on glucose metabolism, fat metabolism and the cardiovascular system in normal human volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2897%2980958-5

7 January 2021

Growth hormone and the immune response to bacterial infection

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2897%2980958-5

7 January 2021

Stimulation of muscle protein synthesis by long-term insulin infusion in severely burned patients

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2897%2980958-5

7 January 2021

The effect of recombinant human IGF-I on protein metabolism in post-operative patients without nutrition compared to effects in experimental animals.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2897%2980958-5

7 January 2021

Whole body protein kinetics in severely septic patients. The response to glucose infusion and total parenteral nutrition

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2897%2980958-5

7 January 2021

Treatment of obese, diet-restricted subjects with growth hormone for 11 weeks: effects on anabolism, lipolysis, and body composition

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2897%2980958-5

7 January 2021

Insulin regulates the serum levels of low molecular weight insulin-like growth factor-binding protein

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2897%2980958-5

7 January 2021

Nutritional regulation of gene expression of insulin-like growth factor-binding proteins and the acid-labile subunit in various tissues of rats

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2897%2980958-5

7 January 2021

Critical illness is associated with low circulating concentrations of insulin-like growth factors-I and -II, alterations in insulin-like growth factor binding proteins, and induction of an insulin-like growth factor binding protein 3 protease.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2897%2980958-5

7 January 2021

Superior potency of infused IGF-I analogues which bind poorly to IGF-binding proteins is maintained when administered by injection

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2897%2980958-5

7 January 2021

Regulation of somatomedin-C/insulin-like growth factor I by nutrients.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2897%2980958-5

7 January 2021

Hormonal and nutritional regulation of IGF-I and its binding proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2897%2980958-5

7 January 2021

Acute Effects of Insulin-like Growth Factor I on Interorgan Glucose and Lactate Flux in Protein-Catabolic Dogs

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2897%2980958-5

7 January 2021

Effects of recombinant human growth hormone in patients with severe sepsis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2897%2980958-5

7 January 2021

Effects of human growth hormone in critically ill nonseptic patients: results from a prospective, randomized, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2897%2980958-5

7 January 2021

Insulin to Inhibit Protein Catabolism after Injury

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2897%2980958-5

7 January 2021

Administration of human recombinant insulin-like growth factor-I in critically ill patients

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2897%2980958-5

7 January 2021

Pathophysiological and clinical aspects of the insulin-like growth factors

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2897%2980958-5

7 January 2021

Insulin-like growth factors I and II: some biological actions and receptor binding characteristics of two purified constituents of nonsuppressible insulin-like activity of human serum

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2897%2980958-5

7 January 2021

Effect of trypsin treatment of rat adipocytes on biological effects and binding of insulin and insulin-like growth factors: further evidence for the action of insulin-like growth factors through the insulin receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2897%2980958-5

7 January 2021

Use of human growth hormone combined with nutritional support in a critical care unit

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2897%2980958-5

7 January 2021

10.1016/S0950-351X(97)80958-5

Identifiers

DOI

1 reference

7 April 2018

PubMed ID

9589777

1 reference

7 April 2018